The special drug use-results survey (All-Case Surveillance) of OfevĀ® Capsules in patients with Idiopathic Pulmonary Fibrosis (IPF) in Japan First published 08/09/2015 Last updated 21/10/2026 EU PAS number:EUPAS10891 Study Finalised